Eastman Chemical Reports Decline in Q4 Earnings
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 29 2026
0mins
Should l Buy EMN?
Source: NASDAQ.COM
- Significant Earnings Drop: Eastman Chemical reported Q4 earnings of $105 million, or $0.92 per share, a sharp decline from $330 million and $2.82 per share last year, indicating substantial profitability challenges for the company.
- Adjusted Earnings Performance: Excluding items, adjusted earnings were $87 million, or $0.75 per share, suggesting that efforts in cost control have not sufficiently offset the overall revenue decline.
- Revenue Decline: The company's Q4 revenue fell to $1.973 billion, a 12.1% decrease from $2.245 billion last year, reflecting challenges from weak market demand and intensified competition.
- Uncertain Market Outlook: With both earnings and revenue declining, Eastman Chemical faces uncertainty in future market performance, which may impact investor confidence and stock price.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EMN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EMN
Wall Street analysts forecast EMN stock price to fall
11 Analyst Rating
6 Buy
5 Hold
0 Sell
Moderate Buy
Current: 79.810
Low
70.00
Averages
74.40
High
80.00
Current: 79.810
Low
70.00
Averages
74.40
High
80.00
About EMN
Eastman Chemical Company is a global specialty materials company that produces a range of products found in items people use every day. Its segments include Advanced Materials (AM), Additives & Functional Products (AFP), Chemical Intermediates (CI), and Fibers. The AM segment produces and markets polymers, films, and plastics with differentiated performance properties for value-added end-uses in transportation; durables and electronics; building and construction; medical and pharma, and consumables end-markets. AFP segment manufactures materials for products in food, feed, and agriculture; transportation; water treatment and energy; personal care and wellness; building and construction; consumables, and durables and electronics end-markets. The CI segment sells intermediates for end-markets, such as industrial chemicals and processing, building and construction, health and wellness, and food and feed. Its Fibers segment manufactures and sells acetate tow and triacetin plasticizers.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
RBC Raises Eastman Chemical Price Target to $79 Amid Q4 Results
- Price Target Increase: RBC Capital has raised Eastman Chemical's price target from $70 to $79, reflecting a more optimistic outlook on the company's future performance while maintaining a 'Sector Perform' rating, indicating a cautious stance.
- Improved Market Sentiment: Investors are increasingly bullish about the potential bottoming of commodity prices; however, RBC analysts caution that Eastman Chemical's products, being mostly 'intermediate', may experience a delayed recovery.
- Competitive Landscape Analysis: The analyst's research note highlights that despite the positive market sentiment, Eastman Chemical's recovery could be impacted by the nature of its products and fluctuations in market demand, necessitating close monitoring of industry trends.
- Earnings Report Impact: The Q4 results for Eastman Chemical prompted analysts to reassess its future growth potential, indicating that while short-term challenges may persist, the long-term outlook remains favorable.
See More
Eastman Chemical Q4 2025 Earnings Call Insights
- Fibers Segment Stabilization: Eastman Chemical has implemented stabilization measures in its Fibers segment, achieving stable contracted volumes despite tariff impacts and consumer pressures, with modest price declines reflecting resilience amid market fluctuations.
- Cost Reduction Targets: The company aims to achieve an additional $125 million to $150 million in cost reductions on top of the previously achieved $100 million, highlighting management's strong focus on enhancing profitability and cash flow through disciplined cost control.
- Chemical Intermediates Project: Eastman's ETP project is projected to improve earnings by $50 million to $100 million, with a capital payback period of less than two years, indicating the company's proactive approach to technological innovation and profitability enhancement.
- Optimistic 2026 Outlook: Management anticipates a meaningful improvement in earnings for 2026, targeting around $6 per share, and while macroeconomic uncertainties persist, the focus on innovation and cost reductions positions Eastman for stable growth.
See More
Eastman Chemical Q4 Revenue Misses Estimates, Shares Drop
- Revenue Decline: Eastman Chemical reported fourth-quarter revenue of $1.97 billion, down from the previous year and below analysts' expectations of $2.02 billion, resulting in a 2.2% drop in after-hours trading due to lower volumes across multiple end markets.
- Earnings Performance: Although adjusted earnings per share were $0.75, exceeding the consensus estimate of $0.72, net income was still impacted by overall revenue decline, highlighting the challenges the company faces in the current economic environment.
- Market Pressures: Sales fell across all major segments, particularly in chemical intermediates and fibers, primarily due to customer inventory destocking and competitive pressures in global commodity markets, exacerbating the decline in performance.
- Future Outlook: Eastman anticipates earnings improvement in 2026 driven by deeper cost reductions and higher utilization rates, although the company refrained from providing a full-year adjusted earnings forecast due to macroeconomic uncertainties.
See More
Eastman Chemical Reports Decline in Q4 Earnings
- Significant Earnings Drop: Eastman Chemical reported Q4 earnings of $105 million, or $0.92 per share, a sharp decline from $330 million and $2.82 per share last year, indicating substantial profitability challenges for the company.
- Adjusted Earnings Performance: Excluding items, adjusted earnings were $87 million, or $0.75 per share, suggesting that efforts in cost control have not sufficiently offset the overall revenue decline.
- Revenue Decline: The company's Q4 revenue fell to $1.973 billion, a 12.1% decrease from $2.245 billion last year, reflecting challenges from weak market demand and intensified competition.
- Uncertain Market Outlook: With both earnings and revenue declining, Eastman Chemical faces uncertainty in future market performance, which may impact investor confidence and stock price.
See More
Eastman Chemical Set to Report Q4 Earnings
- Earnings Announcement Date: Eastman Chemical (EMN) is set to release its Q4 earnings on January 29th after market close, with a consensus EPS estimate of $0.72, reflecting a significant year-over-year decline of 61.5%, indicating substantial pressure on profitability.
- Revenue Expectations Decline: The anticipated revenue for Q4 is $2.02 billion, down 10.2% year-over-year, which highlights the negative impact of weak market demand on the company's performance and may lead to decreased investor confidence.
- Historical Performance Review: Over the past two years, Eastman has beaten EPS estimates 75% of the time but only 50% for revenue, indicating volatility in earnings that could affect future investment decisions.
- Revised Expectations: In the last three months, there have been no upward revisions to EPS estimates, with 14 downward adjustments, and similarly, revenue estimates saw no upward revisions and 11 downward adjustments, reflecting a weakening market outlook for the company.
See More
Eastman Chemical (EMN) Downgraded to Sector Perform with $70 Price Target
- Rating Downgrade: RBC Capital downgraded Eastman Chemical from Outperform to Sector Perform with a $70 price target, indicating the stock is fairly valued amid ongoing weak demand for durables and sustainable products.
- Weak Demand Impact: The analyst highlighted that Eastman's advanced materials segment is suffering from weak durables demand and low asset utilization, leading to a 3% reduction in the 2026 methanolysis earnings estimate to $364 million.
- Investment Delays: Due to the underperformance of the recent Kingsport ramp-up, new project capital investments are likely to be pushed out, reflecting a cautious outlook on future growth opportunities in a challenging market environment.
- Earnings Outlook: While the additives and functional products unit remains relatively stable with a projected 4% EBIT increase to $532 million in 2026, the chemical intermediates segment continues to face spread challenges, suggesting a weak overall outlook.
See More
RBC Raises Eastman Chemical Price Target to $79 Amid Q4 Results
- Price Target Increase: RBC Capital has raised Eastman Chemical's price target from $70 to $79, reflecting a more optimistic outlook on the company's future performance while maintaining a 'Sector Perform' rating, indicating a cautious stance.
- Improved Market Sentiment: Investors are increasingly bullish about the potential bottoming of commodity prices; however, RBC analysts caution that Eastman Chemical's products, being mostly 'intermediate', may experience a delayed recovery.
- Competitive Landscape Analysis: The analyst's research note highlights that despite the positive market sentiment, Eastman Chemical's recovery could be impacted by the nature of its products and fluctuations in market demand, necessitating close monitoring of industry trends.
- Earnings Report Impact: The Q4 results for Eastman Chemical prompted analysts to reassess its future growth potential, indicating that while short-term challenges may persist, the long-term outlook remains favorable.
See More
Eastman Chemical Q4 2025 Earnings Call Insights
- Fibers Segment Stabilization: Eastman Chemical has implemented stabilization measures in its Fibers segment, achieving stable contracted volumes despite tariff impacts and consumer pressures, with modest price declines reflecting resilience amid market fluctuations.
- Cost Reduction Targets: The company aims to achieve an additional $125 million to $150 million in cost reductions on top of the previously achieved $100 million, highlighting management's strong focus on enhancing profitability and cash flow through disciplined cost control.
- Chemical Intermediates Project: Eastman's ETP project is projected to improve earnings by $50 million to $100 million, with a capital payback period of less than two years, indicating the company's proactive approach to technological innovation and profitability enhancement.
- Optimistic 2026 Outlook: Management anticipates a meaningful improvement in earnings for 2026, targeting around $6 per share, and while macroeconomic uncertainties persist, the focus on innovation and cost reductions positions Eastman for stable growth.
See More
Eastman Chemical Q4 Revenue Misses Estimates, Shares Drop
- Revenue Decline: Eastman Chemical reported fourth-quarter revenue of $1.97 billion, down from the previous year and below analysts' expectations of $2.02 billion, resulting in a 2.2% drop in after-hours trading due to lower volumes across multiple end markets.
- Earnings Performance: Although adjusted earnings per share were $0.75, exceeding the consensus estimate of $0.72, net income was still impacted by overall revenue decline, highlighting the challenges the company faces in the current economic environment.
- Market Pressures: Sales fell across all major segments, particularly in chemical intermediates and fibers, primarily due to customer inventory destocking and competitive pressures in global commodity markets, exacerbating the decline in performance.
- Future Outlook: Eastman anticipates earnings improvement in 2026 driven by deeper cost reductions and higher utilization rates, although the company refrained from providing a full-year adjusted earnings forecast due to macroeconomic uncertainties.
See More
Eastman Chemical Reports Decline in Q4 Earnings
- Significant Earnings Drop: Eastman Chemical reported Q4 earnings of $105 million, or $0.92 per share, a sharp decline from $330 million and $2.82 per share last year, indicating substantial profitability challenges for the company.
- Adjusted Earnings Performance: Excluding items, adjusted earnings were $87 million, or $0.75 per share, suggesting that efforts in cost control have not sufficiently offset the overall revenue decline.
- Revenue Decline: The company's Q4 revenue fell to $1.973 billion, a 12.1% decrease from $2.245 billion last year, reflecting challenges from weak market demand and intensified competition.
- Uncertain Market Outlook: With both earnings and revenue declining, Eastman Chemical faces uncertainty in future market performance, which may impact investor confidence and stock price.
See More
Eastman Chemical Set to Report Q4 Earnings
- Earnings Announcement Date: Eastman Chemical (EMN) is set to release its Q4 earnings on January 29th after market close, with a consensus EPS estimate of $0.72, reflecting a significant year-over-year decline of 61.5%, indicating substantial pressure on profitability.
- Revenue Expectations Decline: The anticipated revenue for Q4 is $2.02 billion, down 10.2% year-over-year, which highlights the negative impact of weak market demand on the company's performance and may lead to decreased investor confidence.
- Historical Performance Review: Over the past two years, Eastman has beaten EPS estimates 75% of the time but only 50% for revenue, indicating volatility in earnings that could affect future investment decisions.
- Revised Expectations: In the last three months, there have been no upward revisions to EPS estimates, with 14 downward adjustments, and similarly, revenue estimates saw no upward revisions and 11 downward adjustments, reflecting a weakening market outlook for the company.
See More
Eastman Chemical (EMN) Downgraded to Sector Perform with $70 Price Target
- Rating Downgrade: RBC Capital downgraded Eastman Chemical from Outperform to Sector Perform with a $70 price target, indicating the stock is fairly valued amid ongoing weak demand for durables and sustainable products.
- Weak Demand Impact: The analyst highlighted that Eastman's advanced materials segment is suffering from weak durables demand and low asset utilization, leading to a 3% reduction in the 2026 methanolysis earnings estimate to $364 million.
- Investment Delays: Due to the underperformance of the recent Kingsport ramp-up, new project capital investments are likely to be pushed out, reflecting a cautious outlook on future growth opportunities in a challenging market environment.
- Earnings Outlook: While the additives and functional products unit remains relatively stable with a projected 4% EBIT increase to $532 million in 2026, the chemical intermediates segment continues to face spread challenges, suggesting a weak overall outlook.
See More
